A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects

• Status: Completed
• Trial end date: 2006-01-01
• Target enrollment: 0
• Participant gender: All

Summary

To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Pfizer
• Collaborator: Jasper Clinic, Michigan
• Treatments: Nelfinavir; Omeprazole

Criteria

Inclusion Criteria:

• Healthy male or female subjects between the ages of 18 and 55 years.

Exclusion Criteria:

• Subjects with hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.